2nd Quarter - Report

WILLIAMS AND JENSEN, PLLC for NOVARTIS INC

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety and drug counterfeiting; Drug importation; Authorized generics; Drug company settlements including S. 27, Preserve Access to Affordable Generics Act; Prescription drug advertising; Federal preemption for prescription drugs; Legislation concerning civil litigation; Implementation of Patient Protection and Affordable Care Act; and Reauthorization of the Prescription Drug User Fee Act.

LobbyistCovered position, as disclosed
JENNY DIJAMES —
SUSAN HIRSCHMANN —
KARINA LYNCH —
ERIN BOOK MULLEN New —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 27 (112th)

Budget/Appropriations BUD

Funding for pandemic influenza countermeasures

LobbyistCovered position, as disclosed
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Labor Issues/Antitrust/Workplace LBR

Compensation of drug company employees.

LobbyistCovered position, as disclosed
GEORGE OLSEN New —
DAVID A STARR New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare prescription drug benefit Rebates for Medicare Part D.

LobbyistCovered position, as disclosed
JENNY DIJAMES —
SUSAN HIRSCHMANN —
KARINA LYNCH —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.